Grifols | GRFS - Equity Capital And Reserves

Stock Price
8.08
Daily Change
0.09 1.13%
Monthly
4.80%
Yearly
12.07%
Q2 Forecast
7.87

Grifols reported EUR6.21B in Equity Capital and Reserves for its fiscal quarter ending in December of 2025.





Equity Capital And Reserves Change Date
Alaunos Therapeutics USD 2.8M 858K Sep/2025
Arca Biopharma USD 469M 17.79M Dec/2025
aTyr Pharma USD -24.12M 104.35M Dec/2025
Bio Path USD -8M 846K Sep/2025
Brainstorm Cell Therapeutics USD -9.98M 2.29M Dec/2025
Capricor Therapeutics USD 305.79M 221.92M Dec/2025
Cara Therapeutics USD 27.87M 5.06M Sep/2025
Esperion Therapeutics USD -301.96M 149.4M Dec/2025
GlaxoSmithKline GBP 16.38B 229M Dec/2025
Grifols EUR 6.21B 133.12M Dec/2025
Immunic USD 10.5M 23.41M Sep/2025
Infinity Pharmaceuticals USD -37.41M 9.08M Jun/2023
Minerva Neurosciences USD -140.75M 106.17M Dec/2025
Nektar Therapeutics USD 89.83M 4.75M Dec/2025
Sangamo BioSciences USD 19.6M 14.7M Jun/2025
TherapeuticsMD USD 27.67M 990K Jun/2024